Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Spit, Don't swab: could saliva tests end the trauma of nose swabs for sick kids?

NCT ID NCT07350291

Diagnosis Sponsor: Poitiers University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will compare two ways to test for respiratory viruses in children under 2 years old: the standard, uncomfortable nose swab versus a simple saliva sample. Researchers want to see if saliva is just as accurate at detecting viruses, while being less painful and stressful for kids and their families. If it works, saliva sampling could become a kinder, routine option for diagnosing common winter illnesses like bronchiolitis.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could make diagnosing respiratory infections in children less painful and stressful by using a simple saliva sample instead of a nose swab.
What could go wrong
This is an early-stage study comparing two sampling methods, not testing a new treatment. Saliva may not detect all pathogens as accurately as the standard nose swab.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 502 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Jul 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

28 days to 23 months

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Infants aged between 28 days and under 24 months. * Admission to paediatric A\&E or general paediatrics. * Respiratory conditions requiring treatment for microbiological diagnosis by upper airway sampling. * Collection of consent signed by legal representatives or guardians with parental authority. Except in cases where there is a single parent with parental authority. * Persons affiliated with or beneficiaries of a social security scheme. Exclusion Criteria:• Refusal to participate by one of the legal representatives or the patient. * Patients with a contraindication to ASNA (those with haemophilia, on anticoagulants or with thrombocytopenia). * Patients with a known increased risk of epistaxis (nosebleeds), hypertrophic rhinitis or other conditions causing excessive mucosal fragility. * Participation in another study that would impact the primary objective of this research. * Patients who may be allergic to the material used in the sponge pacifier. * Patients in a life-threatening emergency situation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pediatrics are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pediatrics Virus diseases in children

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.